Celularity Inc. Operating Leases, Rent Expense
Celularity Inc. (CELU) reported Operating Leases, Rent Expense of $668.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2022-03-31
- Celularity Inc. operating leases, rent expense for the quarter ending 2021-12-31 was $66.00K, a 80.30% decline year-over-year.
- Celularity Inc. operating leases, rent expense for the quarter ending 2020-12-31 was $335.00K.
- Celularity Inc. operating leases, rent expense for fiscal 2021 was $668.00K, a 58.56% decline from fiscal 2020.
- Celularity Inc. operating leases, rent expense for fiscal 2020 was $1.61M.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|
| 2021-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $668.00K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $602.00K 10-Q · filed 2021-11-12 | ||
| 2020-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.61M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.28M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |